Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Drug Discovery > U.S. Drug Discovery Contract Research Organization Markets
Category
Pharmaceutical (4988)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (561)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

U.S. Drug Discovery Contract Research Organization Markets

Published by Frost & Sullivan
Published September, 2006 Product code 45126
Content info  
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


U.S. Drug Discovery Contract Research Organization Markets published by Frost & Sullivan in September, 2006. This report price starts from US $ 6000.

Introduction

Abstract

Research Overview

This research service is available through our Pharmaceuticals & Clinical Diagnostics Growth Partnership Service program. With this program, you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils

Table of Contents

  • 1. Executive Summary
    • 1. Executive Summary
      • 1. Executive Summary
  • 2. Overview
    • 1. Overview
      • 1. Introduction
      • 2. Market Segmentation
      • 3. Research Methodology
      • 4. Market Engineering Measurements
  • 3. U.S. Drug Discovery Contract Research Organization Markets
    • 1. Market Drivers Restraints and Trends
      • 1. Market Drivers
      • a. Cost Pressures Encourage Research and Development (R&D) Outsourcing
      • b. Strong Growth of R&D Expenditure by Pharmaceutical and Biotechnology Companies Spurs Market Expansion
      • c. Aging Population and Shift from Acute to Chronic Products Drives Demand for Outsourcing
      • d. Limited Development Infrastructure with Biotechnology and Specialty Pharmaceutical Encourages Demand for Outsourcing
      • e. Robust Biotechnology Funding Drives Outsourcing Volumes
      • f. Toxicology Capacity Addition by Outsourcers Encourages Outsourcing Market Expansion
      • 2. Market Restraints
      • a. Increasing Competition and Commoditization of CRO Services Curtails Margins
      • b. Increasingly Stringent Regulatory Standards Pose an Ongoing Quality Challenge for CROs
      • c. Consolidation of the Pharmaceutical Industry Reduces Potential Revenues for Contract Research
      • d. Small CRO Size Limits Breadth of Offerings, While, Large Size Limits Flexibility
      • 3. Market Trends
    • 2. Revenue Forecasts Demand Analysis and Competitive Structure
      • 1. Revenue Forecasts
      • 2. Demand Analysis
      • 3. Competitive Structure
    • 3. Competitive Analysis
      • 1. Market Share Analysis
    • 4. Frost and Sullivan Awards
      • 1. Business Development Strategy Leadership Award
      • 2. Growth Strategy Leadership Award
      • 3. Market Leadership Award
  • 4. Challenges and Strategies
    • 1. Industry Challenges & Strategies
      • 1. Industry Challenges
      • 2. Strategies
  • 5. Decision Support Databases
    • 1. Pharmaceuticals and Biotechnology
      • 1. Pharmaceutical Research and Development Expenditure
      • 2. Biotechnology Companies
      • 3. Private Investment in Biotechnology Companies
      • 4. Biotechnology Government Research and Development Expenditure
    • 2. Macro Economic and Demographic Indicators
      • 1. Nominal GDP Growth
      • 2. Total Population
Back to Top